Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journals of gerontology. Series A, Biological sciences and medical sciences Biological sciences and medical sciences, 2017-07, Vol.72 (11), p.1513-1522
Hauptverfasser:	Tompkins, Bryon A, DiFede, Darcy L, Khan, Aisha, Landin, Ana Marie, Schulman, Ivonne Hernandez, Pujol, Marietsy V, Heldman, Alan W, Miki, Roberto, Goldschmidt-Clermont, Pascal J, Goldstein, Bradley J, Mushtaq, Muzammil, Levis-Dusseau, Silvina, Byrnes, John J, Lowery, Maureen, Natsumeda, Makoto, Delgado, Cindy, Saltzman, Russell, Vidro-Casiano, Mayra, Da Fonseca, Moisaniel, Golpanian, Samuel, Premer, Courtney, Medina, Audrey, Valasaki, Krystalenia, Florea, Victoria, Anderson, Erica, El-Khorazaty, Jill, Mendizabal, Adam, Green, Geoff, Oliva, Anthony A, Hare, Joshua M
Format:	Artikel
Sprache:	eng
Schlagworte:	The Journal of Gerontology: Translational : Stem Cell Transplantation for Frailty
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!